Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2535350018 | Selective adhesion molecule inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3520821011 | Substance with selective adhesion molecule inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3559317015 | Substance with selective adhesion molecule inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selective adhesion molecule inhibitor | Is a | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Has disposition (attribute) | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Has disposition (attribute) | Immunomodulator (disposition) | false | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Is a | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alpha-4 integrin receptor antagonist | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | |
| Product containing selective adhesion molecule inhibitor (product) | Has active ingredient | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | 1 |
| Crizanlizumab (substance) | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some |
This concept is not in any reference sets
FHIR